FDA, Covid-19 and vaccine
Digest more
Top News
Overview
Impacts
In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only to people over 65 years old or those with an underlying health condition.
The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months and older.
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration.
Explore more